blue cross blue shield plans reverse course on glp-1 coverage Digital health company Ro launches
Description
INTRODUCTION In patients with type 2 diabetes with overweight and no cardiovascular disease or moderate risk of cardiovascular disease, metformin is the recommended initial treatment (class IIa recommendation)
2024;12(4) doi: 10.1080/21688370.2023.2292461
Rybelsus remains the appropriate oral GLP-1 choice for adults with type 2 diabetes seeking glycaemic control without injectable therapy and able to follow the fasting protocol
GLP-1 drugs do the same
Moreover, ccontinuous infusion of GLP-1 upregulated islet Pdx-1 gene expression and induced -cell proliferation and neogenesis in rats [58]
